High impact paper in Nature Reviews Drug Discovery
We recently published a high impact paper together with the TransQST consortium in Nature Reviews Drug Discovery, which has an impact factor of 102. It highlights the advancements in the development of in vitro models for predicting drug toxicity, along with recommendations for their application in drug discovery and development.
The paper can be found here: https://doi.org/10.1038/s41573-025-01308-z
Also read
-
Join 4 Energy Donates €50,000 for Muscle Stem Cell Therapy Research
Prof. Dr. Bert Smeets and his team has received a €50,000 donation from Join4Energy to advance their pioneering research using mesoangioblasts derived from the patient’s own body.
-
Denise Slenter Joins the BioSB Board as 'YoungCB' Portfolio Leader: request for PhD representative, and members
Denise Slenter Joins the BioSB Board as 'YoungCB' Portfolio Leader: request for PhD representative, and members
-
Macrophages as key to treating liver fibrosis
Sabine Daemen is researching how certain macrophages can slow down fatty liver disease and fibrosis in order to develop new therapies.
